ZL-1310 ASCO 2025 Highlights June 2, 2025 NASDAQ:ZLAB | HKEX:9688 © 2024. Zai Lab. All Rights Reserved. Associate Director of Drug Development, Sarah Cannon Research Institute Forward-Looking Statements This presentation contains forward-looking statements about future expectations, plans, and prospects for Zai Lab, including, without limitation, statements regarding product candidates in our pipeline including ZL-1310 and related clinical trials and preclinical studies, the potential benefits and safety an ...